Shaoming Zhu

99 Zhangzhidong Road
E'zhou, 430060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

A biotin guided PtIV amphiphilic prodrug synergized with CDK4/6 inhibition for enhanced tumor targeted therapy.

A biotin guided PtIV amphiphilic prodrug synergized with CDK4/6 inhibition for enhanced tumor targeted therapy.

Journal: Nanoscale

Published: March 26, 2025

TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB.

TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB.

Journal: Cancers

Published: August 15, 2022

Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer.

Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 28, 2022

Corrigendum: Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer.

Corrigendum: Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer.

Journal: Frontiers in oncology

Published: March 31, 2022

Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer.

Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer.

Journal: Frontiers in oncology

Published: September 11, 2021

Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer.

Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer.

Journal: Journal for immunotherapy of cancer

Published: August 31, 2021

SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/β-catenin pathway.

SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/β-catenin pathway.

Journal: Journal of cellular and molecular medicine

Published: August 11, 2021

Combination strategies to maximize the benefits of cancer immunotherapy.

Combination strategies to maximize the benefits of cancer immunotherapy.

Journal: Journal of hematology & oncology

Published: July 29, 2021

Preclinical Models for Bladder Cancer Research.

Preclinical Models for Bladder Cancer Research.

Journal: Hematology/oncology clinics of North America

Published: May 07, 2021

TSPAN7 Exerts Anti-Tumor Effects in Bladder Cancer Through the PTEN/PI3K/AKT Pathway.

TSPAN7 Exerts Anti-Tumor Effects in Bladder Cancer Through the PTEN/PI3K/AKT Pathway.

Journal: Frontiers in oncology

Published: October 04, 2020

Traditional Classification and Novel Subtyping Systems for Bladder Cancer.

Traditional Classification and Novel Subtyping Systems for Bladder Cancer.

Journal: Frontiers in oncology

Published: August 02, 2019

Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis.

Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis.

Journal: OncoTargets and therapy

Published: March 29, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026